BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 7612529)

  • 21. Predictive power progesterone combined with beta human chorionic gonadotropin measurements in the outcome of threatened miscarriage.
    Duan L; Yan D; Zeng W; Yang X; Wei Q
    Arch Gynecol Obstet; 2011 Mar; 283(3):431-5. PubMed ID: 20107822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The early pregnancy factor (EPF) as an early marker of disorders in pregnancy].
    Straube W; Römer T; Zeenni L; Loh M
    Zentralbl Gynakol; 1995; 117(1):32-4. PubMed ID: 7879460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Doppler and biochemical assessment for the prediction of early pregnancy outcome in patients experiencing threatened spontaneous abortion.
    Shehata NAA; Ali HAA; Hassan AEGMA; Katta MA; Ali ASF
    Int J Gynaecol Obstet; 2018 Nov; 143(2):150-155. PubMed ID: 30058068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prognostic significance of maternal serum CA125 measurement in threatened abortion.
    Oçer F; Beşe T; Saridoğan E; Aydinli K; Atasü T
    Eur J Obstet Gynecol Reprod Biol; 1992 Sep; 46(2-3):137-42. PubMed ID: 1451890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Relation of serum estradiol and progesterone levels with abortive anticipation in pregnant women with fetal irritability and vaginal bleeding].
    Lou YY; Fu P; Liu XR
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Nov; 30(11):1153-6. PubMed ID: 21275165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pregnancy outcome of threatened abortion with subchorionic hematoma: possible benefit of bed-rest?
    Ben-Haroush A; Yogev Y; Mashiach R; Meizner I
    Isr Med Assoc J; 2003 Jun; 5(6):422-4. PubMed ID: 12841015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Day 14 maternal serum progesterone levels predict pregnancy outcome in IVF/ICSI treatment cycles: a prospective study.
    Ioannidis G; Sacks G; Reddy N; Seyani L; Margara R; Lavery S; Trew G
    Hum Reprod; 2005 Mar; 20(3):741-6. PubMed ID: 15591085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycodelin serum levels in women with ectopic pregnancy.
    Foth D; Römer T
    Eur J Obstet Gynecol Reprod Biol; 2003 Jun; 108(2):199-202. PubMed ID: 12781411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hormonal considerations in early normal pregnancy and blighted ovum syndrome.
    Schweditsch MO; Dubin NH; Jones GS; Wentz AC
    Fertil Steril; 1979 Mar; 31(3):252-7. PubMed ID: 437159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Qualitative blood flow parameters in the spiral artery and progesterone concentration in pregnancy complicated by threatened abortion].
    Persona-Sliwińska A; Brazert J; Piekarski T; Miedzianowski J; Biczysko R
    Ginekol Pol; 2001 Oct; 72(10):772-7. PubMed ID: 11848012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioactive to immunoreactive ratio of circulating human chorionic gonadotropin as possible evaluation for the prognosis of threatened abortion.
    Camejo MI; Proverbio F; Febres F; Casart YC
    Eur J Obstet Gynecol Reprod Biol; 2003 Aug; 109(2):181-4. PubMed ID: 12860338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ultrasonic assessment of complications during first trimester of pregnancy.
    Stabile I; Campbell S; Grudzinskas JG
    Lancet; 1987 Nov; 2(8570):1237-40. PubMed ID: 2890856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can pregnancy-associated plasma protein A (PAPP-A) predict the outcome of pregnancy in women with threatened abortion and confirmed fetal viability?
    Ruge S; Pedersen JF; Sørensen S; Lange AP
    Acta Obstet Gynecol Scand; 1990; 69(7-8):589-95. PubMed ID: 1709769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of vaginal progesterone on pain and uterine contractility in patients with threatened abortion before twelve weeks of pregnancy.
    Palagiano A; Bulletti C; Pace MC; DE Ziegler D; Cicinelli E; Izzo A
    Ann N Y Acad Sci; 2004 Dec; 1034():200-10. PubMed ID: 15731312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Signs and symptoms associated with early pregnancy loss: findings from a population-based preconception cohort.
    Sapra KJ; Buck Louis GM; Sundaram R; Joseph KS; Bates LM; Galea S; Ananth CV
    Hum Reprod; 2016 Apr; 31(4):887-96. PubMed ID: 26936888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How can we better predict the risk of spontaneous miscarriage among women experiencing threatened miscarriage?
    Ku CW; Allen JC; Malhotra R; Chong HC; Tan NS; Østbye T; Lek SM; Lie D; Tan TC
    Gynecol Endocrinol; 2015; 31(8):647-51. PubMed ID: 26036717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating levels of placental protein 14 in ectopic pregnancy.
    Stabile I; Olajide F; Chard T; Grudzinskas JG
    Br J Obstet Gynaecol; 1994 Sep; 101(9):762-4. PubMed ID: 7947525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical use of a model to predict the viability of early intrauterine pregnancies when no embryo is visible on ultrasound.
    Lautmann K; Cordina M; Elson J; Johns J; Schramm-Gajraj K; Ross JA
    Hum Reprod; 2011 Nov; 26(11):2957-63. PubMed ID: 21926057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaginal bleeding and early pregnancy outcome in an infertile population.
    Dantas ZN; Singh AP; Karachalios P; Asch RH; Balmaceda JP; Stone SC
    J Assist Reprod Genet; 1996 Mar; 13(3):212-5. PubMed ID: 8852881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serial hCG and progesterone levels to predict early pregnancy outcomes in pregnancies of uncertain viability: A prospective study.
    Puget C; Joueidi Y; Bauville E; Laviolle B; Bendavid C; Lavoué V; Le Lous M
    Eur J Obstet Gynecol Reprod Biol; 2018 Jan; 220():100-105. PubMed ID: 29202392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.